$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

$fcuv Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000168316821001866 Filed on May 10, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$363.5K	$310.6K
YoY Change	17.02%	101.85%
Cost Of Revenue	$292.3K	$338.1K
YoY Change	-13.55%	156.64%
Gross Profit	$71.20K	-$27.46K
YoY Change	-359.26%	-223.98%
Gross Profit Margin	19.59%	-8.84%
Selling, General & Admin	$417.4K	$404.9K
YoY Change	3.1%	265.9%
% of Gross Profit	586.28%
Research & Development	$63.15K	$70.40K
YoY Change	-10.29%	13.53%
% of Gross Profit	88.69%
Depreciation & Amortization	$40.54K	$40.60K
YoY Change	-0.15%	23.3%
% of Gross Profit	56.93%
Operating Expenses	$1.083M	$942.8K
YoY Change	14.83%	68.95%
Operating Profit	-$719.2K	-$970.3K
YoY Change	-25.88%	81.06%
Interest Expense	-$7.530K	$1.200K
YoY Change	-727.5%	64.38%
% of Operating Profit
Other Income/Expense, Net	$36.68K	$47.98K
YoY Change	-23.55%	6517.24%
Pretax Income	-$682.5K	-$922.3K
YoY Change	-26.0%	72.34%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$682.5K	-$922.3K
YoY Change	-26.0%	72.34%
Net Earnings / Revenue	-187.78%	-296.93%
Basic Earnings Per Share	-$0.02
Diluted Earnings Per Share	-$0.02	-$22.52K
COMMON SHARES
Basic Shares Outstanding	40.96M shares	40.96M shares
Diluted Shares Outstanding	40.96M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.908M	$1.493M
YoY Change	27.79%	-57.99%
Cash & Equivalents	$1.908M	$1.493M
Short-Term Investments
Other Short-Term Assets	$37.91K	$40.34K
YoY Change	-6.02%	-43.69%
Inventory	$24.81K	$77.18K
Prepaid Expenses	$37.91K	$40.34K
Receivables	$347.9K	$231.5K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.319M	$1.866M
YoY Change	24.25%	-55.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.452M	$4.613M
YoY Change	-3.49%	-2.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.630K	$6.630K
YoY Change	0.0%	-52.1%
Total Long-Term Assets	$4.534M	$4.738M
YoY Change	-4.31%	-9.62%
TOTAL ASSETS
Total Short-Term Assets	$2.319M	$1.866M
Total Long-Term Assets	$4.534M	$4.738M
Total Assets	$6.853M	$6.604M
YoY Change	3.76%	-30.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$0.00	$314.7K
YoY Change	-100.0%
Accrued Expenses	$55.89K	$46.42K
YoY Change	20.4%	-9.57%
Deferred Revenue	$3.927K	$104.7K
YoY Change	-96.25%
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$355.0K
YoY Change
Total Short-Term Liabilities	$762.5K	$472.0K
YoY Change	61.53%	28.55%
LONG-TERM LIABILITIES
Long-Term Debt	$1.806M	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$17.14K	$12.34K
YoY Change	38.91%	-91.45%
Total Long-Term Liabilities	$1.849M	$94.63K
YoY Change	1854.06%	-38.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$762.5K	$472.0K
Total Long-Term Liabilities	$1.849M	$94.63K
Total Liabilities	$2.612M	$566.7K
YoY Change	360.86%	8.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.40M	-$8.101M
YoY Change	28.36%	82.02%
Common Stock	$40.96K	$40.96K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.241M	$6.038M
YoY Change
Total Liabilities & Shareholders Equity	$6.853M	$6.604M
YoY Change	3.76%	-30.23%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$682.5K	-$922.3K
YoY Change	-26.0%	72.34%
Depreciation, Depletion And Amortization	$40.54K	$40.60K
YoY Change	-0.15%	23.3%
Cash From Operating Activities	-$438.8K	-$649.6K
YoY Change	-32.45%	75.98%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	$0.00	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.764M	-$50.00K
YoY Change	-3627.39%	2374.02%
NET CHANGE
Cash From Operating Activities	-$438.8K	-$649.6K
Cash From Investing Activities	$0.00	$0.00
Cash From Financing Activities	$1.764M	-$50.00K
Net Change In Cash	$1.325M	-$699.6K
YoY Change	-289.39%	-22.34%
FREE CASH FLOW
Cash From Operating Activities	-$438.8K	-$649.6K
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$438.8K	-$649.6K
YoY Change	-32.45%	18.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40959741	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40959741	shares
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	FOCUS UNIVERSAL INC.
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001590418
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	.001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2021Q1	us-gaap	Revenues Revenues	363463	usd
CY2020Q1	us-gaap	Revenues Revenues	310609	usd
CY2021Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	236250	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	140000	shares
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4837958	usd
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4837958	usd
CY2021Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	377547	usd
CY2020Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	433539	usd
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2021Q1	dei	Entity File Number EntityFileNumber	000-55247
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	292263	usd
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	338072	usd
CY2021Q1	us-gaap	Gross Profit GrossProfit	71200	usd
CY2020Q1	us-gaap	Gross Profit GrossProfit	-27463	usd
CY2021Q1	us-gaap	Officers Compensation OfficersCompensation	39100	usd
CY2020Q1	us-gaap	Officers Compensation OfficersCompensation	34000	usd
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	63150	usd
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	70396	usd
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	310084	usd
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	389813	usd
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	790393	usd
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	942818	usd
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-719193	usd
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-970281	usd
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-7533	usd
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1275	usd
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	36677	usd
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	47975	usd
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-682516	usd
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-922306	usd
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12000	usd
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	4240934	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	4804612	usd
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	6688575	usd
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	6037619	usd
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40959741	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40959741	shares
CY2021Q1	us-gaap	Selling Expense SellingExpense	512	usd
CY2020Q1	us-gaap	Selling Expense SellingExpense	15070	usd
CY2021Q1	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	0	usd
CY2020Q1	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	81	usd
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	44210	usd
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	46781	usd
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-682516	usd
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-922306	usd
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	16295	usd
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	16295	usd
CY2021Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	0	usd
CY2020Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	17471	usd
CY2021Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	267297	usd
CY2020Q1	us-gaap	Proceeds From Loans ProceedsFromLoans	0	usd
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	385985	usd
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	345448	usd
CY2021Q1	us-gaap	Security Deposit Liability SecurityDepositLiability	12335	usd
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	73025	usd
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	128707	usd
CY2021Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.15	pure
CY2021Q1	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2022-08-31
CY2021Q1	us-gaap	Security Deposit SecurityDeposit	5968	usd
CY2021Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	7565	usd
CY2020Q1	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	0	usd
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40959741	shares
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6852511	usd
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5593328	usd
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10398630	usd
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9716114	usd
CY2021Q1	FCUV	Shares To Be Issued Common Share SharesToBeIssuedCommonShare	110709	usd
CY2020Q4	FCUV	Shares To Be Issued Common Share SharesToBeIssuedCommonShare	98709	usd
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14487896	usd
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14381058	usd
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	40959	usd
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	40959	usd
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q1	us-gaap	Liabilities Liabilities	2611577	usd
CY2020Q4	us-gaap	Liabilities Liabilities	788716	usd
CY2021Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1849073	usd
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	261157	usd
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17135	usd
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17135	usd
CY2021Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	1805536	usd
CY2020Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	202735	usd
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	26402	usd
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	41287	usd
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	82292	usd
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	762504	usd
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	527559	usd
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	55890	usd
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	53384	usd
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	46415	usd
CY2021Q1	us-gaap	Loans Payable Current LoansPayableCurrent	355021	usd
CY2020Q4	us-gaap	Loans Payable Current LoansPayableCurrent	194125	usd
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3927	usd
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	57377	usd
CY2021Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6332	usd
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6332	usd
CY2021Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	341334	usd
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	198870	usd
CY2021Q1	us-gaap	Assets Assets	6852511	usd
CY2020Q4	us-gaap	Assets Assets	5593328	usd
CY2021Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6630	usd
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6630	usd
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	75016	usd
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	86558	usd
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118544	usd
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4451973	usd
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4492510	usd
CY2021Q1	us-gaap	Assets Current AssetsCurrent	2318892	usd
CY2020Q4	us-gaap	Assets Current AssetsCurrent	1007630	usd
CY2021Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	0	usd
CY2020Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	100000	usd
CY2021Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	37913	usd
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	91253	usd
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	347924	usd
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	190556	usd
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40959741	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40959741	shares
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	106838	usd
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	259350	usd
CY2021Q1	FCUV	Common Stock To Be Issued For Services Value CommonStockToBeIssuedForServicesValue	12000	usd
CY2020Q1	FCUV	Common Stock To Be Issued For Services Value CommonStockToBeIssuedForServicesValue	12000	usd
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	5437	usd
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	1831	usd
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021Q1	us-gaap	Cash Cash	1908247	usd
CY2020Q4	us-gaap	Cash Cash	583325	usd
CY2019Q4	us-gaap	Cash Cash	2192870	usd
CY2020Q1	us-gaap	Cash Cash	1493283	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1324922	usd
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-699587	usd
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1763697	usd
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-50000	usd
CY2021Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	1500000	usd
CY2020Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
CY2021Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	usd
CY2020Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	50000	usd
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-438775	usd
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-649587	usd
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-53450	usd
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-22984	usd
CY2021Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
CY2020Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-1750	usd
CY2021Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0	usd
CY2020Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-12334	usd
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-17471	usd
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	0	usd
CY2021Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-53340	usd
CY2020Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-6634	usd
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-20975	usd
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14437	usd
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	0	usd
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	23977	usd
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	165725	usd
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	94161	usd
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	837	usd
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	378	usd
CY2021Q1	us-gaap	Depreciation Depreciation	40537	usd
CY2020Q1	us-gaap	Depreciation Depreciation	40598	usd
CY2021Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	-3287	usd
CY2020Q1	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	189	usd
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8357	usd
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><u>Use of Estimates</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying financial statements include the lease term impacting right-of use asset and lease liability, useful lives of property and equipment, useful lives of intangible assets, allowance for doubtful accounts, inventory reserves, debt discounts, valuation of derivatives, and the valuation allowance on deferred tax assets. The Company regularly evaluates its estimates and assumptions.</p>
CY2021Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><u>Concentrations of Credit Risk</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company limits its exposure to credit loss by investing its cash with high credit quality financial institutions.</p>
CY2021Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><u>Reclassification</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain reclassifications have been made to the condensed consolidated financial statements for prior years to the current year’s presentation. Such reclassifications have no effect on net income as previously reported.</p>
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	52876	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	44519	usd
CY2021Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	67275	usd
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	70562	usd
CY2021Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	40180	usd
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	45509	usd
CY2021Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	51903	usd
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	67549	usd
CY2021Q1	us-gaap	Inventory Gross InventoryGross	92083	usd
CY2020Q4	us-gaap	Inventory Gross InventoryGross	113058	usd
CY2021Q1	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	67275	usd
CY2020Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	70562	usd
CY2021Q1	us-gaap	Inventory Net InventoryNet	24808	usd
CY2020Q4	us-gaap	Inventory Net InventoryNet	42496	usd
CY2021Q1	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	82197	usd
CY2020Q1	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	38669	usd
CY2021Q1	us-gaap	Deferred Costs Leasing Gross DeferredCostsLeasingGross	157213	usd
CY2020Q1	us-gaap	Deferred Costs Leasing Gross DeferredCostsLeasingGross	157213	usd
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	91928	usd
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	43655	usd
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	48273	usd
CY2021Q1	us-gaap	Loans Payable LoansPayable	2160557	usd
CY2020Q4	us-gaap	Loans Payable LoansPayable	396860	usd
CY2021Q1	us-gaap	Loans Payable To Bank LoansPayableToBank	1496400	usd
CY2020Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	0	usd
CY2021Q1	us-gaap	Other Loans Payable OtherLoansPayable	664157	usd
CY2020Q4	us-gaap	Other Loans Payable OtherLoansPayable	396860	usd
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9636	usd
CY2021Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2020Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2021Q1	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	267297	usd
CY2020Q1	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	0	usd
CY2021Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-100000	usd
CY2020Q1	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	0	usd
CY2021Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	3600	usd
CY2020Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	0	usd
CY2021Q1	FCUV	Share Based Compensation Options ShareBasedCompensationOptions	106838	usd
CY2020Q1	FCUV	Share Based Compensation Options ShareBasedCompensationOptions	259350	usd
CY2021Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	142464	usd
CY2020Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	123969	usd

Files In Submission

Name	View Source	Status
fcuv-20210331_cal.xml	Edgar Link	unprocessable
0001683168-21-001866-index-headers.html	Edgar Link	pending
0001683168-21-001866-index.html	Edgar Link	pending
0001683168-21-001866.txt	Edgar Link	pending
0001683168-21-001866-xbrl.zip	Edgar Link	pending
fcuv-20210331.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
focus_10q-033121.htm	Edgar Link	pending
focus_10q-ex3101.htm	Edgar Link	pending
focus_10q-ex3102.htm	Edgar Link	pending
focus_10q-ex3201.htm	Edgar Link	pending
focus_10q-ex3202.htm	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
fcuv-20210331_def.xml	Edgar Link	unprocessable
fcuv-20210331_lab.xml	Edgar Link	unprocessable
fcuv-20210331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
fcuv-20210331.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv

2021 Q1 Form 10-Q Financial Statement

#000168316821001866 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV FOCUS UNIVERSAL INC. Stock $fcuv

2021 Q1 Form 10-Q Financial Statement

#000168316821001866 Filed on May 10, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FCUV
FOCUS UNIVERSAL INC. Stock $fcuv